News | December 04, 2008

ContextVision Enters Interventional Radiology Market With 
GOPView iRVPlus Offering Image Enhancement, Dose Reduction

December 5, 2008 – ContextVision introduced its GOPView iRVPlus, a new image enhancement and dose reduction software package for interventional radiology, this week at RSNA 2008 in Chicago.

Clinical teams rely on this type of tool during fluoroscopy procedures, such as angioplasty or stent replacement, during which real-time images are used to guide catheters to the target location. GOPView iRVPlus relies on a continuous adaptive filtration method to analyze every pixel in an image, giving every structure in the image the same level of analysis. This rotationally invariant process guarantees that all objects, independent of position and orientation, receive the highest level of image enhancement possible. This eliminates the risk of critical information being overlooked during a procedure, leading to higher clinical value.

Like all ContextVision products, iRVPlus relies on a proprietary algorithm, GOP, which simultaneously enhances all structures and reduces noise. This anisotropic filtration method enhances image quality of all textures so that more details can be seen while introducing less blur. Additionally, an extensive and growing library of adaptive filters fine-tunes images.

For more information: www.contextvision.com


Additional Content

News | Angiography

Oct. 21, 2025 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home October 24, 2025
Home
News | Angiography

Sept. 30, 2025 — Cleerly has announced that coverage policies from UnitedHealthcare and Cigna for Cleerly LABS advanced ...

Home September 30, 2025
Home
News | Angiography

July 28, 2025 — AngioDynamics, Inc. has announced enrollment of the first patient in the Randomized Study of the Auryon ...

Home July 28, 2025
Home
News | Angiography

April 25, 2025 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) meeting, SCAI 2025 Scientific ...

Home April 25, 2025
Home
News | Angiography

March 17, 2025 – Ostial Corp., a privately held medical technology company focused on addressing the clinical challenges ...

Home March 18, 2025
Home
Subscribe Now